Related Experiment Video
Updated: Jul 25, 2026

Lumped-Parameter and Finite Element Modeling of Heart Failure with Preserved Ejection Fraction
Published on: February 13, 2021
Modern trends in the management of heart failure
1Department of Medicine, University of Kansas Medical Center, Kansas City 66103.
Insights
Managing heart failure involves a range of medications and close monitoring. Judicious treatment, including diuretics and vasodilators, can significantly improve patient outcomes and quality of life.
Area of Science:
- Cardiology
- Pharmacology
Background:
- Heart failure management has evolved with numerous therapeutic options.
- Effective treatment requires careful patient evaluation and monitoring.
Purpose of the Study:
- To review current and emerging pharmacologic therapies for heart failure.
- To emphasize the importance of individualized treatment regimens and close surveillance.
Main Methods:
- Review of available literature on heart failure pharmacotherapy.
- Discussion of established treatments (diuretics, digitalis, vasodilators, anticoagulants).
- Exploration of novel agents (e.g., phosphodiesterase inhibitors) and advanced interventions (heart transplantation).
Main Results:
- Diuretics are foundational, with other agents used for progressive disease.
- Phosphodiesterase inhibitors show future promise.
- Heart transplantation offers significant benefits for selected end-stage patients.
Conclusions:
- Multidrug regimens and vigilant monitoring are crucial for moderate to severe heart failure.
- Balancing therapeutic effects and side effects (e.g., congestion vs. hypotension) requires precise titration.
- Judicious and timely treatment can lead to dramatic improvements in heart failure management.
Abstract:
An increasing number of medications are available to the physician treating heart failure. Initial therapy involves diuretics, with digitalis, vasodilators, and anticoagulants used for progressive disease. Additional medications such as the phosphodiesterase inhibitors offer promise for the future. In selected patients, the results of heart transplantation have been extremely gratifying and frequently can return the patient with end-stage heart failure to a near-normal life-style. The physician should be mindful that most patients with heart failure need frequent attention and evaluation. Many patients with moderate to severe heart failure require multidrug regimens and close surveillance to detect electrolyte imbalance or evidence of decompensation at an early stage. Often a tenuous balance exists between pulmonary vascular congestion and orthostatic hypotension, and week-to-week or day-to-day titration of diuretic and vasodilator therapy is required. While the care of the patient with heart failure often requires considerable time and resources, judicious treatment can lead to dramatic improvement and is frequently rewarding to both the patient and physician.
More Related Videos
Related Concept Videos
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
Heart Failure IV: Classification and Diagnostic Evaluation
Heart Failure V: Medical Management
Heart Failure VI: Adjunct Therapies
Heart Failure VII: Nursing Interventions
Cardiomyopathy V: Interprofessional Care

